-
61.
公开(公告)号:SK5712003A3
公开(公告)日:2003-11-04
申请号:SK5712003
申请日:2001-10-11
Applicant: SERVIER LAB
Inventor: FAUCHERE JEAN-LUC , ORTUNO JEAN-CLAUDE , LEVENS NIGEL , CHAMORRO SUSANA , BOUTIN JEAN ALBERT
IPC: C07D249/14 , A61K31/4196 , A61K31/422 , A61K31/428 , A61K31/4439 , A61K31/4709 , A61K31/55 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/12 , A61P15/10 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D401/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , C07D417/12
Abstract: A compound of formula (I): wherein: R1 and R2 represent hydrogen or a group as defined in the description, R3 represents hydrogen or alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl or heterocycloalkyl, R4 represents a group of formula (II): wherein W and B are as defined in the description, R5 represents hydrogen or alkyl, A represents a group selected from -A2-, -A1-A2-, -A2-A1- and -A1-A2-A1-, V is as defined in the description.
-
公开(公告)号:DK1252150T3
公开(公告)日:2003-09-29
申请号:DK01904021
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , A61K31/4353
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
公开(公告)号:HU0204354A2
公开(公告)日:2003-04-28
申请号:HU0204354
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: BENNEJEAN CAROLINE , BLANC-DELMAS ELODIE , BOUTIN JEAN ALBERT , DACQUET CATHERINE , DEPREUX PATRICK , GUILLAUMET GERALD , LESIEUR DANIEL , LEVENS NIGEL , RENARD PIERRE , YOUS SAID
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
公开(公告)号:DK1044970T3
公开(公告)日:2003-04-22
申请号:DK00401039
申请日:2000-04-14
Applicant: SERVIER LAB
Inventor: FAUCHERE JEAN-LUC , ORTUNO JEAN-CLAUDE , DUHAULT JACQUES , BOUTIN JEAN ALBERT , LEVENS NIGEL
IPC: C07D249/08 , A61K31/4196 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/501 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/12 , A61P15/00 , A61P15/10 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D249/12 , C07D249/14 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D409/12
Abstract: 1,2,4-Triazolylamino-substituted carboxamide or hydrazide derivatives (I) are new. Triazole derivatives of formula G-NH-A- CO-NH-(NH)n-W-Z (I) and their enantiomers, diastereoisomers and acid or base addition salts are new. G = 1,2,4-triazolyl group of formula (G1)-(G4); n = 0 or 1; W = CO, S, SO or SO2; Z, R1 = alkyl or (all optionally substituted) aryl, heteroaryl, aralkyl, aralkenyl, aralkynyl, heteroaralkyl, heteroaralkenyl or heteroaralkynyl; A = -A2-, -A1-A-2-, -A2-A1- or -A1-A2-A1-; A1 = alkylene; A2 = phenylene, naphthylene, cycloalkylene or heteroarylene (all optionally substituted); R = H or as Z. Alkyl or alkylene groups have 1-6C; alkenyl/alkynyl groups have 2-6C and 1-3 double/triple bonds; cycloalkylene groups have 3-6C; aryl groups are phenyl, naphthyl, biphenylyl, dihydronaphthyl or tetrahydronaphthyl; heteroaryl moieties are 5-11 membered, mono- or bicyclic and unsaturated or partially unsaturated, and contain 1-4 of O, S and N as heteroatoms; arylene or heteroarylene moieties are the divalent analogs of arylene and heteroarylene respectively; optionally substituted, in the case of aryl, aralkyl, heteroaryl and heteroaralkyl, indicates that the groups are optionall ring-substituted by 1-5 of alkyl, alkoxy, halo, OH, perhaloalkyl, NO2, NH2, mono- or dialkylamino, 1-6C acyl, CONH2, mono- or di-alkylaminocarbonyl, 1-6C acylamino, alkoxycarbonyl, CHO, COOH, SO3H, CN, aminoalkyl, mono- or dialkylaminoalkyl, thioalkyl, alkylthioalkyl, hydroxyalkyl or alkoxyalkyl; optionally substituted, in the case of phenylene, naphthylene and heteroarylene, indicates that the groups are optionally substituted by 1-3 of alkyl, alkoxy, halo, OH, perhaloalkyl, NO2, NH2, mono- or dialkylamino, 1-6C acyl, CHO, COOH, alkoxycarbonyl, CONH2, mono- or di-alkylaminocarbonyl, 1-6C acylamino or CN. An Independent claim is included for the preparation of (I).
-
公开(公告)号:SK11162002A3
公开(公告)日:2003-01-09
申请号:SK11162002
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , A61K31/4353
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
66.
公开(公告)号:HU0200913A2
公开(公告)日:2002-11-28
申请号:HU0200913
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: BOUSSARD MARIE-FRANCOISE , BOUTIN JEAN ALBERT , DELAGRANGE PHILIPPE , ROUSSEAU ANNE , WIERZBICKI MICHEL
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
公开(公告)号:CZ20022646A3
公开(公告)日:2002-11-13
申请号:CZ20022646
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , A61K31/4353
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
公开(公告)号:NO20023662L
公开(公告)日:2002-09-27
申请号:NO20023662
申请日:2002-08-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
公开(公告)号:NO20023662A
公开(公告)日:2002-09-27
申请号:NO20023662
申请日:2002-08-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04
CPC classification number: C07D263/58 , C07D277/68 , C07D471/04
-
公开(公告)号:CA2424802A1
公开(公告)日:2002-04-18
申请号:CA2424802
申请日:2001-10-11
Applicant: SERVIER LAB
Inventor: BOUTIN JEAN ALBERT , FAUCHERE JEAN-LUC , ORTUNO JEAN-CLAUDE , LEVENS NIGEL , CHAMORRO SUSANA
IPC: C07D249/14 , A61K31/4196 , A61K31/422 , A61K31/428 , A61K31/4439 , A61K31/4709 , A61K31/55 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/12 , A61P15/10 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D401/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , C07D417/12
Abstract: Composé de formule (I), dans laquelle: R3 représente un atome d'hydrogène ou un groupement alkyle, alkényle, alkynyle, aryle, hétéroaryle, cycloalkyle ou hétérocycloalkyle; R4 représente un groupement de formule (II), dans laquell e B représente un groupement mono ou polycyclique, aromatique ou non, contenan t 3 à 10 sommets, pouvant contenir de 1 à 3 hétéroatomes, R5 représente un ato me d'hydrogène ou un groupement alkyle, A représente un groupement choisi parmi - A2-, -A1-A2, -A2-A1- ou -A1-A2-A1-; V représente une liaison ou un groupemen t - CH2-, -CO-, -CS-, -CH2-NH- ou -CH=N-, ou V et R3 forment ensemble avec les groupements -A- et -N-R4 qui les portent un groupement -A-CH=N-R4, et leur utilisation dans le traitement des pathologies liées au neuropeptide Y (NPY) .
-
-
-
-
-
-
-
-
-